Physician

Tayson Delengocky, D.O

According to 2025 Medicare claims, Tayson Delengocky, D.O (NPI: 1164637153) practices ophthalmology in the El Centro, CA market, with the plurality of this provider's patient population coming from Imperial, CA. This provider's primary affiliated billing organization is CALIFORNIA RETINA ASSOCIATES, LP (NPI: 1114033404; TIN: 330298426) and primary practice location at 92243-9676.

Delengocky's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,848 traditional Medicare patients, billed 8,622 HCPCS/CPT codes, and received $607,942 in Medicare payments. The top billing code was 92235 (Exam of retinal blood vessels using a special camera after injection of a dye). Part D data shows 10,093 prescription claims across 1,986 beneficiaries totaling $2,008,302 in drug costs, led by Cyclosporine (Cyclosporine). Open Payments data shows 50 records totaling $1,064. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $1,032,541 to $607,942. In contrast, Part D prescription costs have moved sharply higher in recent years, from $1,164,936 to $2,008,302. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$516K$1.0M2015 Medicare payment: $1,032,541 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $943,494 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $903,951 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $875,336 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $766,620 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $663,334 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $771,018 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $611,802 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $587,283 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $607,942 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,99511,974$1,032,541
20161,91412,602$943,494
20171,87610,629$903,951
20181,82511,069$875,336
20191,5799,521$766,620
20201,5227,546$663,334
20211,8819,869$771,018
20221,7999,138$611,802
20231,8728,476$587,283
20241,8488,622$607,942

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.3M$2.6M2015 Drug cost: $1,164,936 (USD; Tot_Drug_Cst)2016 Drug cost: $1,251,415 (USD; Tot_Drug_Cst)2017 Drug cost: $1,416,178 (USD; Tot_Drug_Cst)2018 Drug cost: $1,372,525 (USD; Tot_Drug_Cst)2019 Drug cost: $1,200,114 (USD; Tot_Drug_Cst)2020 Drug cost: $1,335,903 (USD; Tot_Drug_Cst)2021 Drug cost: $1,800,225 (USD; Tot_Drug_Cst)2022 Drug cost: $2,379,305 (USD; Tot_Drug_Cst)2023 Drug cost: $2,622,945 (USD; Tot_Drug_Cst)2024 Drug cost: $2,008,302 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151,5527,854$1,164,936
20161,5598,050$1,251,415
20171,5678,628$1,416,178
20181,6519,130$1,372,525
20191,4608,623$1,200,114
20201,6869,709$1,335,903
20211,81411,492$1,800,225
20221,81911,847$2,379,305
20231,92611,014$2,622,945
20241,98610,093$2,008,302

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92235Exam of retinal blood vessels using a special camera after injection of a dye607633$128
92014Established patient complete exam of visual system1,4202,075$89
92134Imaging of retina6671,005$31
92250Photography of the retina1,3531,560$27
92133Imaging of optic nerve498564$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
CyclosporineCyclosporine81548,341$462,655
XiidraLifitegrast32514,760$322,397
CequaCyclosporine33114,490$279,973
RestasisCyclosporine30112,930$265,281
RocklatanNetarsudil Mesylat/Latanoprost39010,424$135,378

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.50$1,064Bausch & Lomb Americas Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Tayson Delengocky, D.O?

Tedicare shows public-source Medicare data for Tayson Delengocky, D.O (NPI 1164637153), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Tayson Delengocky, D.O have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Tayson Delengocky, D.O?

Tayson Delengocky, D.O is linked to CALIFORNIA RETINA ASSOCIATES, LP (billing NPI 1114033404) in the available physician profile data.

Does Tayson Delengocky, D.O have Open Payments data?

Tayson Delengocky, D.O has 50 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.